Pernod Ricard expects FY26 organic net sales to decline due to Middle East conflict
Overview
France spirits and wine maker's Q3 FY26 organic net sales grew 0.1% amid volatile market
Nine-month organic net sales fell 4.4%, impacted by FX and disposals
Company expects FY26 organic net sales to decline 3-4% due to Middle East conflict
Outlook
Pernod Ricard, which is in talks to merge with U.S. rival Brown-Forman, expects FY26 organic net sales to decline by 3% to 4%
Company aims for c.16% A&P investment ratio and strategic investments below €700 mln in FY26
Medium term (FY27-29), company projects organic net sales growth of 3%-6% per year
Result Drivers
VOLUME RECOVERY - Group volumes returned to growth in Q3, with total group volumes up 4% and Strategic International Brands up 3%
REGIONAL VARIATION - Strong growth in emerging markets and several mature markets offset declines in the US (-12%) and China (-7%)
INNOVATION & CONSUMER TRENDS - Co cited new product launches, affordability initiatives, and consumer experience activations as supporting sales momentum
Company press release: ID:nBw72x73ba
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
9M Sales |
|
EUR 7.20 bln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 10 "hold" and 2 "sell" or "strong sell"
The average consensus recommendation for the distillers & wineries peer group is "buy"
Wall Street's median 12-month price target for Pernod Ricard SA is €92.00, about 37.3% above its April 15 closing price of €67.00
The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 12 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
